Does menopause increase the risk of developing kidney stones?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Menopause and Kidney Stone Risk

Menopause is associated with a higher risk of incident kidney stones, with postmenopausal women having approximately 27% increased risk compared to premenopausal women. 1

Relationship Between Menopause and Kidney Stone Risk

  • Postmenopausal status is independently associated with higher risk of kidney stone formation (multivariate adjusted relative risk 1.27; 95% CI 1.08-1.46) compared to premenopausal status 1
  • Both natural menopause (RR 1.27; 95% CI 1.09-1.48) and surgical menopause (RR 1.43; 95% CI 1.19-1.73) are independently associated with increased kidney stone risk 1
  • The protective effect of estrogen against kidney stone formation diminishes after menopause, which may explain the increased risk in postmenopausal women 2

Physiological Mechanisms

  • Menopause leads to significant changes in urine composition that may promote stone formation:

    • Lower urinary calcium, citrate, phosphorus, and uric acid excretion 1
    • Higher urine volume (which may be compensatory) 1
    • Lower urinary saturation of stone-forming salts in premenopausal women compared to men, which may explain the lower risk of stone formation in premenopausal women 2
  • Estrogen appears to have protective effects against kidney stone formation through:

    • Reducing urinary calcium excretion 2
    • Lowering calcium oxalate saturation in urine 2
    • These protective effects are lost during menopause 2, 1

Impact of Hormone Replacement Therapy

  • Estrogen-treated postmenopausal women have lower 24-hour urinary calcium (155 ± 62 vs 193 ± 90 mg/day) and lower calcium oxalate saturation (5.07 ± 2.27 vs 6.48 ± 3.44) compared to untreated postmenopausal women 2
  • However, neither current nor past hormone replacement therapy use has been significantly associated with kidney stone risk in large observational studies 1
  • Meta-analysis data suggests no significant association between postmenopausal hormone therapy and the risk of nephrolithiasis (pooled relative risk 0.91; 95% CI 0.72-1.14) 3

Additional Risk Factors in Postmenopausal Women

  • Multivariate risk factors for kidney stones in postmenopausal women include:
    • History of hypertension 4
    • Low dietary intake of magnesium 4
    • Low use of calcium supplements 4
  • Women with chronic kidney disease experience menopause at a younger age (median 47 years vs 50-51 years in women with normal renal function), which may further increase their kidney stone risk 5, 6

Clinical Implications

  • Regular assessment of kidney stone risk factors is essential for postmenopausal women 5
  • Adequate fluid intake to achieve urine volume >2.5 liters daily is recommended to prevent new stones 7
  • Reduced sodium intake is advised to decrease the risk of stone formation 7
  • Supplemental calcium intake >500 mg/day may be inversely associated with stone occurrence in postmenopausal women 4

Pitfalls and Caveats

  • The relationship between menopause and kidney stones may be confounded by age-related changes in metabolism and diet 1, 8
  • Surgical menopause appears to carry a higher risk for kidney stone formation than natural menopause 1, 8
  • While hormone replacement therapy shows some beneficial effects on urinary parameters, it is not currently recommended solely for kidney stone prevention 2, 1
  • The impact of obesity on kidney stone risk is particularly pronounced in females 7

References

Research

Menopause and Risk of Kidney Stones.

The Journal of urology, 2018

Research

Risk factors for kidney stones in older women in the southern United States.

The American journal of the medical sciences, 2001

Guideline

Cardiovascular Effects of Menopause in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Uric Acid Kidney Stones in Obese Individuals

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Menopause and postmenopausal hormone use and risk of incident kidney stones.

Journal of the American Society of Nephrology : JASN, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.